Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus

Mitsuteru Akahoshi, Hitoshi Nakashima, Taro Shirakawa

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a complex genetic basis that includes many susceptibility genes on multiple chromosomes. As complex human diseases like SLE involve multiple, interacting genetic and environmental determinants, identifying genes for complex traits is challenging and has had limited success so far. However, recent advances in genetic resources and technology have been providing new tools to identify the novel pathways or the sequence variants that contribute to autoimmune diseases. During the past several years, several new candidate genes have been implicated in development of SLE though association studies. In this article we describe an overview of the latest findings in the genetics of SLE, especially focusing on the genetic variations in the signalling or immunoregulatory molecules including CD28 and IRF family members.

Original languageEnglish
Pages (from-to)224-229
Number of pages6
JournalSeminars in Immunology
Volume18
Issue number4
DOIs
Publication statusPublished - Aug 1 2006

Fingerprint

Systemic Lupus Erythematosus
Autoimmune Diseases
Genes
Chromosomes
Technology

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology

Cite this

Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus. / Akahoshi, Mitsuteru; Nakashima, Hitoshi; Shirakawa, Taro.

In: Seminars in Immunology, Vol. 18, No. 4, 01.08.2006, p. 224-229.

Research output: Contribution to journalReview article

@article{47559437d0884693aa0b70b59d0a990d,
title = "Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus",
abstract = "Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a complex genetic basis that includes many susceptibility genes on multiple chromosomes. As complex human diseases like SLE involve multiple, interacting genetic and environmental determinants, identifying genes for complex traits is challenging and has had limited success so far. However, recent advances in genetic resources and technology have been providing new tools to identify the novel pathways or the sequence variants that contribute to autoimmune diseases. During the past several years, several new candidate genes have been implicated in development of SLE though association studies. In this article we describe an overview of the latest findings in the genetics of SLE, especially focusing on the genetic variations in the signalling or immunoregulatory molecules including CD28 and IRF family members.",
author = "Mitsuteru Akahoshi and Hitoshi Nakashima and Taro Shirakawa",
year = "2006",
month = "8",
day = "1",
doi = "10.1016/j.smim.2006.03.010",
language = "English",
volume = "18",
pages = "224--229",
journal = "Seminars in Immunology",
issn = "1044-5323",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus

AU - Akahoshi, Mitsuteru

AU - Nakashima, Hitoshi

AU - Shirakawa, Taro

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a complex genetic basis that includes many susceptibility genes on multiple chromosomes. As complex human diseases like SLE involve multiple, interacting genetic and environmental determinants, identifying genes for complex traits is challenging and has had limited success so far. However, recent advances in genetic resources and technology have been providing new tools to identify the novel pathways or the sequence variants that contribute to autoimmune diseases. During the past several years, several new candidate genes have been implicated in development of SLE though association studies. In this article we describe an overview of the latest findings in the genetics of SLE, especially focusing on the genetic variations in the signalling or immunoregulatory molecules including CD28 and IRF family members.

AB - Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a complex genetic basis that includes many susceptibility genes on multiple chromosomes. As complex human diseases like SLE involve multiple, interacting genetic and environmental determinants, identifying genes for complex traits is challenging and has had limited success so far. However, recent advances in genetic resources and technology have been providing new tools to identify the novel pathways or the sequence variants that contribute to autoimmune diseases. During the past several years, several new candidate genes have been implicated in development of SLE though association studies. In this article we describe an overview of the latest findings in the genetics of SLE, especially focusing on the genetic variations in the signalling or immunoregulatory molecules including CD28 and IRF family members.

UR - http://www.scopus.com/inward/record.url?scp=33745164942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745164942&partnerID=8YFLogxK

U2 - 10.1016/j.smim.2006.03.010

DO - 10.1016/j.smim.2006.03.010

M3 - Review article

C2 - 16678436

AN - SCOPUS:33745164942

VL - 18

SP - 224

EP - 229

JO - Seminars in Immunology

JF - Seminars in Immunology

SN - 1044-5323

IS - 4

ER -